Latin America Swine Vaccines Market: By Vaccine Type (Inactivated Vaccines, Recombinant vaccines, Live attenuated vaccines, DNA vaccines, Subunit vaccines, Others), By Disease Type (Viral Infections, Bacterial Infections, Parasitic Infection, Fungal Infections, Others), By Distribution Channel (Veterinary Hospitals, Veterinary Pharmacies, Online Pharmacies), and Country 

Purchase Option

$ 3100
$ 4600
$ 6900

Latin America Swine Vaccines Market size was valued at USD x billion in 2022 and is expected to reach USD x billion by 2029, at a CAGR of x% from 2023 to 2029. Vaccines are the biological preparations that provide acquired immunity to the particular disease. Vaccine typically contains the agent that resembles a disease-causing microorganism and made from the killed or weakened forms of microbe, its surface proteins, or toxins. Swine vaccines are manufactured for the prevention or cure of various diseases in swine. Most commonly occurred diseases in swine include parasitic diseases, foodborne diseases, and infectious diseases among others. These vaccines prevent the diseases and make the swine healthy. The swine flu vaccination industry is growing due to a decline in immunity and an increase in the prevalence of epidemic swine flu infection. Respiratory illnesses are caused by swine flu. It is caused by a virus that mutates quickly, allowing it to penetrate both vaccine-induced and natural protection. This virus can spread from animals to humans, resulting in the emergence of new, potentially pandemic strains.

Latin America Swine Vaccines Market Dynamics

High demand for healthy pork meat and rise in pork meat production, Rise in prevalence of various infectious and foodborne diseases and expansion of business by the market players, Grow in adoption of newer vaccines and development in economic growth. Restraints: Stringent regulatory policies for the swine vaccine approval, Adverse effects such as allergies associated with the vaccines, High cost of vaccines and lack of awareness about the swine diseases in underdeveloped countries.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

Latin America Swine Vaccines Market Segmentation

By Vaccine Type
  • Inactivated Vaccines
  • Recombinant vaccines
  • Live attenuated vaccines
  • DNA vaccines
  • Subunit vaccines
  • Others
By Disease Type
  • Viral Infections
  • Bacterial Infections
  • Parasitic Infection
  • Fungal Infections
  • Others
By Distribution Channel
  • Veterinary Hospitals
  • Veterinary Pharmacies
  • Online Pharmacies

Frequently Asked Questions

Zoetis , Merck & Co. Inc, Virbac S.A., Boehringer Ingelheim Vetmedica, Elanco, Bayer Animal Health , Ceva Sante Animale

The report covers the countries market data: Brazil, Mexico, Argentina

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

1.Executive Summary
2. Latin America Swine Vaccines Market Introduction 
2.1. Latin America Swine Vaccines Market  - Taxonomy
2.2. Latin America Swine Vaccines Market  - Definitions
2.2.1.Vaccine Type
2.2.2.Disease Type
2.2.3.Distribution Channel
2.2.4.Country
3. Latin America Swine Vaccines Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4. Latin America Swine Vaccines Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5. Latin America Swine Vaccines Market  By Vaccine Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Inactivated Vaccines
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Recombinant vaccines
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Live attenuated vaccines
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. DNA vaccines
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Subunit vaccines
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Others
5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6. Latin America Swine Vaccines Market  By Disease Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Viral Infections
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Bacterial Infections
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Parasitic Infection
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Fungal Infections
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7. Latin America Swine Vaccines Market  By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Veterinary Hospitals
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Veterinary Pharmacies
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Online Pharmacies
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8. Latin America Swine Vaccines Market  By Country, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. Brazil
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Mexico
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Rest of LA
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
9.Brazil Latin America Swine Vaccines Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Vaccine Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Inactivated Vaccines
9.1.2.Recombinant vaccines
9.1.3.Live attenuated vaccines
9.1.4.DNA vaccines
9.1.5.Subunit vaccines
9.1.6.Others
9.2.  Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Viral Infections
9.2.2.Bacterial Infections
9.2.3.Parasitic Infection
9.2.4.Fungal Infections
9.2.5.Others
9.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Veterinary Hospitals
9.3.2.Veterinary Pharmacies
9.3.3.Online Pharmacies
10.Mexico Latin America Swine Vaccines Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Vaccine Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Inactivated Vaccines
10.1.2.Recombinant vaccines
10.1.3.Live attenuated vaccines
10.1.4.DNA vaccines
10.1.5.Subunit vaccines
10.1.6.Others
10.2.  Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Viral Infections
10.2.2.Bacterial Infections
10.2.3.Parasitic Infection
10.2.4.Fungal Infections
10.2.5.Others
10.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Veterinary Hospitals
10.3.2.Veterinary Pharmacies
10.3.3.Online Pharmacies
11.Rest of LA Latin America Swine Vaccines Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Vaccine Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Inactivated Vaccines
11.1.2.Recombinant vaccines
11.1.3.Live attenuated vaccines
11.1.4.DNA vaccines
11.1.5.Subunit vaccines
11.1.6.Others
11.2.  Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Viral Infections
11.2.2.Bacterial Infections
11.2.3.Parasitic Infection
11.2.4.Fungal Infections
11.2.5.Others
11.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Veterinary Hospitals
11.3.2.Veterinary Pharmacies
11.3.3.Online Pharmacies
12.2.  Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Viral Infections
12.2.2.Bacterial Infections
12.2.3.Parasitic Infection
12.2.4.Fungal Infections
12.2.5.Others
12.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Veterinary Hospitals
12.3.2.Veterinary Pharmacies
12.3.3.Online Pharmacies
13.2.  Disease Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Viral Infections
13.2.2.Bacterial Infections
13.2.3.Parasitic Infection
13.2.4.Fungal Infections
13.2.5.Others
13.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Veterinary Hospitals
13.3.2.Veterinary Pharmacies
13.3.3.Online Pharmacies
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Zoetis
14.2.2.Merck & Co. Inc. 
14.2.3.Virbac S.A
14.2.4.Boehringer Ingelheim Vetmedica 
14.2.5.Elanco
14.2.6.Bayer Animal Health
14.2.7.Ceva Sante Animale
15. Research Methodology 
16. Appendix and Abbreviations 
  • Zoetis 
  • Merck & Co. Inc
  • Virbac S.A.
  • Boehringer Ingelheim Vetmedica
  • Elanco
  • Bayer Animal Health 
  • Ceva Sante Animale

Adjacent Markets